Is GeneDx, the Stock Cathie Wood Bought for 7 Straight Days, Actually Cheap? Mar 12, 2026 Life Science
Seeking a Bottom in Choppy Markets? Two Long-Term Picks with “Anti-Fragile” Qualities Mar 12, 2026 Life Science, Technology
This Cathie Wood-Favored Gene-Editing Stock Is Up 47% This Year. Is It Poised to Take Off? Mar 8, 2026 Life Science
Forget AI and Weight-Loss Drugs: Why Vertex Pharmaceuticals Is the Silent Compounder You Need Feb 22, 2026 Life Science
Why Alnylam Soared 6%: One Analyst Says the Biotech’s Growth Story Is Just Getting Started Feb 17, 2026 Life Science
CRISPR Therapeutics Soars as Partner Vertex Drops Optimistic 2026 Sales Guidance Feb 13, 2026 Life Science
